Pharmacokinetics of Esomeprazole Following Varying Intravenous Administration Rates
Mohammad Niazi, Kerstin Röhss(AstraZeneca (Sweden)), Patrik Bondarov(AstraZeneca (Sweden)), Mohammed Hassan‐Alin(AstraZeneca (United Kingdom)), Hans Rydholm, Henrik Ahlbom(AstraZeneca (Sweden)), Anna Karlsson(Lund University)
Cited by 6
Related Papers
Pharmacokinetics and pharmacodynamics of esomeprazole, the S‐isomer of omeprazole
|Alimentary Pharmacology & Therapeutics|2001|175
Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects
|European Journal of Clinical Pharmacology|2000|140
Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole
|British Journal of Clinical Pharmacology|1998|124
Effect of Esomeprazole 40 mg vs Omeprazole 40 mg on 24-Hour Intragastric pH in Patients with Symptoms of Gastroesophageal Reflux Disease
|Digestive Diseases and Sciences|2002|93
Effect of Once Daily Intravenous and Oral Omeprazole on 24-Hour Intragastric Acidity in Healthy Subjects
|Scandinavian Journal of Gastroenterology|1993|58